We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...

New solutions support high-precision analytics for process development, batch release, and regulatory compliance.

QIAcuity digital PCR kits, assays and protocols for lentivirus-based therapies support quality control in cell and gene ...

A proposal for the impeachment of US President Donald Trump has been submitted to the House of Representatives, Michigan ...

Q1 2025 Management View CEO Kevin Kim reported net income of $21.1 million, or $0.17 per diluted common share, for Q1 2025.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of product and partnership updates designed ...

Last Tuesday, PNP Directorate for Police Community Relations (DPCR) chief Maj. Gen. Roderick B. Alba announced they will be piloting PNP Chinese-Filipino Community Help Desk in areas with ...

In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR ...